Dr. Robert C. Lowe, MD

Dr. Lowe practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Lowe's NPI, 1073590774, was assigned on December 23, 2005. Dr. Lowe graduated from Harvard Medical School in 1992. Dr. Lowe holds Massachusetts license 79548.

Dr. Lowe's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Lowe's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. The medical group on file is Boston University Medical Group (Boston University Internal Medicine Associates). Dmand AI also links Dr. Lowe to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lowe practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lowe's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lowe is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Lowe is licensed in Massachusetts.

CMS data shows 84 Medicare services from Dr. Lowe across 4 procedure codes in 2024, for 107 Medicare patients. Medicare paid $7,598 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 107 Medicare patients who saw Dr. Lowe in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lowe's median patient age at 56, with 50% women.

In 2024, Dr. Lowe wrote 233 Medicare Part D claims for 51 patients. 77% of them were for generic drugs. CMS names the drug for 128 of them, across 6 drugs with 11 or more claims each, at $48,646 in total drug cost. In 2023, CMS named 128 claims across 6 drugs.

Dr. Lowe accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lowe, more than 53% of the clinicians it reports for that procedure.

Dmand AI links Dr. Lowe to 2 clinical trials. Conditions studied include Eosinophilic Esophagitis and Esophagitis. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Lowe that name 3 trials.

CMS Open Payments shows 3 general payments to Dr. Lowe from 2 drug and device companies from 2021 to 2023. Consulting fees make up the largest share, 59% of the total. Sanofi and Genzyme US Companies paid the most, $500. It also lists 23 research payments totaling $44,525 from 2020 to 2025, naming 3 clinical trials.

Dr. Lowe graduated from Harvard Medical School in 1992.